JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
First Trust RBA American Industrial Renaissance ETF
AIRR
$9.26B
| $6.62M | ﹤0.01% |
85,884
+35,336
| +70% | +$2.82M |
2023 Q1
7 quarters
|
|
|
TDAY
3002
USA Today Co
TDAY
$1.04B
| $6.62M | ﹤0.01% |
1,307,463
+287,804
| +28% | +$1.53M |
2017 Q4
28 quarters
|
|
3003
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.3B
| $6.6M | ﹤0.01% |
176,547
+164,419
| +1,356% | +$6.42M |
2023 Q1
7 quarters
|
|
|
NEE.PRT
3004
NextEra Energy 7.234% Corporate Units
NEE.PRT
$1.37B
| $6.6M | ﹤0.01% |
+144,733
| New | +$6.82M |
2024 Q4
0 quarters
|
|
|
TRTX
3005
TPG RE Finance Trust
TRTX
$471M
| $6.6M | ﹤0.01% |
776,262
-91,965
| -11% | -$801K |
2017 Q4
28 quarters
|
|
3006
Powell Industries
POWL
$7.14B
| $6.58M | ﹤0.01% |
89,103
+8,529
| +11% | +$762K |
2015 Q4
36 quarters
|
|
3007
BioLife Solutions
BLFS
$1.82B
| $6.58M | ﹤0.01% |
253,585
-24,748
| -9% | -$616K |
2019 Q2
22 quarters
|
|
3008
Zura Bio
ZURA
$394M
| $6.58M | ﹤0.01% |
2,633,185
+2,611,532
| +12,061% | +$9.3M |
2023 Q2
6 quarters
|
|
3009
First Bancorp
FBNC
$2.58B
| $6.58M | ﹤0.01% |
149,661
+45,052
| +43% | +$2.01M |
2013 Q2
46 quarters
|
|
3010
Global Ship Lease
GSL
$1.65B
| $6.57M | ﹤0.01% |
301,176
-89,877
| -23% | -$2.1M |
2020 Q4
16 quarters
|
|
|
JWN
3011
DELISTED
Nordstrom
JWN
| $6.57M | ﹤0.01% |
271,955
-116,841
| -30% | -$2.7M |
2013 Q2
46 quarters
|
|
3012
CALL
Shell
SHEL
$274B
| $6.56M | ﹤0.01% |
104,700
-8,900
| -8% | -$583K |
2024 Q2
2 quarters
|
|
3013
PUT
PG&E
PCG
$37B
| $6.56M | ﹤0.01% |
325,000
-275,000
| -46% | -$5.59M |
2024 Q2
2 quarters
|
|
3014
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$304M
| $6.56M | ﹤0.01% |
150,668
+23,972
| +19% | +$1.1M |
2023 Q3
5 quarters
|
|
3015
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$764M
| $6.54M | ﹤0.01% |
158,728
-2,941
| -2% | -$123K |
2014 Q3
41 quarters
|
|
3016
Cadre Holdings
CDRE
$1.07B
| $6.51M | ﹤0.01% |
201,675
+35,136
| +21% | +$1.25M |
2021 Q4
12 quarters
|
|
3017
Intellia Therapeutics
NTLA
$1.72B
| $6.51M | ﹤0.01% |
558,518
-90,536
| -14% | -$1.41M |
2017 Q4
28 quarters
|
|
3018
PUT
Lockheed Martin
LMT
$117B
| $6.51M | ﹤0.01% |
13,400
-33,000
| -71% | -$18M |
2024 Q2
2 quarters
|
|
3019
CALL
Sony
SONY
$139B
| $6.51M | ﹤0.01% |
307,500
| – | – |
2023 Q1
7 quarters
|
|
3020
Peapack-Gladstone Financial
PGC
$790M
| $6.5M | ﹤0.01% |
202,865
+55,363
| +38% | +$1.84M |
2017 Q4
28 quarters
|
|
3021
Rocket Pharmaceuticals
RCKT
$281M
| $6.48M | ﹤0.01% |
515,528
-41,024
| -7% | -$618K |
2018 Q2
26 quarters
|
|
3022
Alight
ALIT
$234M
| $6.47M | ﹤0.01% |
46,732
-46,470
| -50% | -$6.82M |
2021 Q3
13 quarters
|
|
3023
Ibotta
IBTA
$838M
| $6.47M | ﹤0.01% |
99,372
+93,498
| +1,592% | +$6.49M |
2024 Q2
2 quarters
|
|
3024
CALL
XPO
XPO
$21.8B
| $6.47M | ﹤0.01% |
+49,300
| New | +$6.66M |
2024 Q4
0 quarters
|
|
3025
CALL
Fidelity National Information Services
FIS
$16.7B
| $6.46M | ﹤0.01% |
80,000
| – | – |
2024 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.